Corbus Pharmaceuticals Holdings Inc. (CRBP) is priced at $1.46 after the most recent trading session. At the very opening of the session, the stock price was $1.40 and reached a high price of $1.46, prior to closing the session it reached the value of $1.41. The stock touched a low price of $1.32.
Recently in News on November 12, 2020, Corbus Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference. Fireside chat with live audio webcast on Thursday, November 19th at 12:35 PM EST. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Corbus Pharmaceuticals Holdings Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.5000 on 01/06/21, with the lowest value was $1.2300 for the same time period, recorded on 01/04/21.
Corbus Pharmaceuticals Holdings Inc. (CRBP) full year performance was -76.86%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Corbus Pharmaceuticals Holdings Inc. shares are logging -85.07% during the 52-week period from high price, and 60.44% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.91 and $9.78.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 9425347 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Corbus Pharmaceuticals Holdings Inc. (CRBP) recorded performance in the market was 16.80%, having the revenues showcasing 21.67% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 125.30M, as it employees total of 141 workers.
The Analysts eye on Corbus Pharmaceuticals Holdings Inc. (CRBP)
During the last month, 0 analysts gave the Corbus Pharmaceuticals Holdings Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.3243, with a change in the price was noted -6.0350. In a similar fashion, Corbus Pharmaceuticals Holdings Inc. posted a movement of -80.52% for the period of last 100 days, recording 5,853,029 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CRBP is recording 0.61 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.61.
Technical rundown of Corbus Pharmaceuticals Holdings Inc. (CRBP)
Raw Stochastic average of Corbus Pharmaceuticals Holdings Inc. in the period of last 50 days is set at 64.71%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 44.44%. In the last 20 days, the company’s Stochastic %K was 40.12% and its Stochastic %D was recorded 38.27%.
Considering, the past performance of Corbus Pharmaceuticals Holdings Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 16.80%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -79.61%, alongside a downfall of -76.86% for the period of the last 12 months. The shares increased approximately by 14.96% in the 7-day charts and went up by 9.36% in the period of the last 30 days. Common stock shares were driven by 21.67% during last recorded quarter.